Tuberculosis Market Research Reports & Industry Analysis
The Mantoux test is used in the United States and is endorsed by the American Thoracic Society and Centers for Disease Control and Prevention (CDC). Multiple puncture tests such as the Tine test are not recommended. The Mantoux test is one of the two major tuberculin skin tests for tuberculosis used in the world.
As a replacement for the Mantoux test, several other tests are being developed. QuantiFERON®-TB Gold, manufactured by Cellestis Limited (Carnegie, Victoria, Australia) is a blood test that measures the patient’s immune reactivity to the M. tuberculosis and is useful for initial and serial testing of persons with an increased risk of latent or active tuberculosis infection. Guidelines for the use of QuantiFERON-®TB Gold were released by the CDC in December of 2005. QuantiFERON®-TB Gold is FDA approved in the United States; has CE Mark approval in Europe; and has been approved by the MHLW in Japan. Sputum smears and cultures should be done for acid-fast bacilli if the patient is producing sputum. The preferred method for this is fluorescence microscopy (auramine-rhodamine staining), which is more sensitive than conventional Ziehl- Neelsen staining.
Tuberculosis Industry Research & Market Reports
-
Tuberculosis Diagnostics Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “Tuberculosis Diagnostics Market Outlook to 2030- Forecasts ... Read More
-
Anti-infective Vaccines Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increased Occurrence of New and Re-emerging Infectious Illnesses Driving Market ... Read More
-
Bovine Diagnostics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products), Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Types], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
... Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Types], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography The bovine diagnostics ... Read More
-
Tuberculosis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.28% during 2023-2028. Tuberculosis (TB) refers to an infectious bacterial disease that primarily affects the lungs (pulmonary), along with other parts of the ... Read More
-
Anti-Tuberculosis Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030
... markets. The global anti-tuberculosis therapeutics market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are growing prevalence of ... Read More
-
Tuberculosis Diagnosis and Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price ... Read More
-
Tuberculosis Vaccine Treatment Industry Research Report 2023
... joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it ... Read More
-
Pulmonary Tuberculosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Pulmonary Tuberculosis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Global Antituberculosis Agent-9 Market Growth 2023-2029
... % from 2023 to 2029. United States market for Antituberculosis Agent-9 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. China ... Read More
-
Mycobacterium Tuberculosis Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033
... and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Mycobacterium Tuberculosis Tests market for the ... Read More
-
Anti-Tuberculosis Therapeutics Market by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2023-2028
... US$ 1,354.79 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,991.34 Million by 2028, exhibiting a growth rate (CAGR) of 6.70% during 2023-2028. The rising healthcare spending, favorable reimbursement policies, ... Read More
-
Point-of-Care Diagnostics Market by Platform (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood Glucose Monitoring, Hematology, Tumor), Sample Type (Blood, Urine), and End User—Global Forecast to 2030
... (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood Glucose Monitoring, Hematology, Tumor), Sample Type (Blood, Urine), and End User—Global Forecast to 2030 The global point-of-care diagnostics market is projected to reach $43.1 ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Size study & Forecast, by Diagnostics Test Type (Radiographic Test, Laboratory Test, Nucleic Acid Testing, Cytokine Detection Test, Other Diagnostic Test Types), by End-User (Hospitals/ Clinics, Diagnostics/ Research Laboratory, Other End-Users), and Regional Analysis, 2022-2029
... End-Users), and Regional Analysis, 2022-2029 Global Tuberculosis (TB) Diagnostics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the ... Read More
-
Global Active Tuberculosis Treatment Market Growth 2023-2029
... CAGR of % from 2023 to 2029. United States market for Active Tuberculosis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Global Tuberculosis Screening Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. United States market for Tuberculosis Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Molecular Diagnostics Market - By Product (Instruments, Reagents & Kits), By Technology (Polymerase Chain Reaction, Hybridization, Sequencing, Microarrays), By Application (Infectious Disease Diagnostics {COVID-19, HIV, CT/NG, Hepatitis B, Hepatitis C, RSV, Flu, Tuberculosis}, Genetic Disease Testing), By End-use (Diagnostics Laboratories, Hospitals & Clinics) & Forecast, 2023 - 2032
... Testing), By End-use (Diagnostics Laboratories, Hospitals & Clinics) & Forecast, 2023 - 2032 Molecular diagnostics market is poised to witness lucrative gains through 2032, owing to the surging geriatric population. As per WHO, 1 in ... Read More
-
Respiratory Disease Testing Market - By Test Type (Mechanical Tests {Spirometry, Pulmonary Function Test, Blood Gas Test}, Imaging Tests {X-ray, CT-scan, Ultrasonography, MRI}, In-vitro Diagnostic Tests {Point-of-care Test, Molecular Diagnostic Test}), By Application (COPD, Lung Cancer, Asthma, Tuberculosis) By End-use (Diagnostic Centers, Hospitals, Clinics) & Forecast, 2023 - 2032
... Cancer, Asthma, Tuberculosis) By End-use (Diagnostic Centers, Hospitals, Clinics) & Forecast, 2023 - 2032 Respiratory disease testing market is anticipated to register substantial revenue gains through 2032, owing to high exposure to dust particles coupled ... Read More
-
Global Tuberculosis Treatment Market Report and Forecast 2023-2031
... CAGR of 6.7% during the forecast period of 2023-2031 to reach a value of USD 3.2 billion by 2031. The market growth can be attributed to the increasing prevalence of tuberculosis, the rising awareness about ... Read More
-
Infectious Disease Diagnostics Market, By Technique ( ELISA, Polymerase Chain Reaction (PCR),Immunoassays, Cell Cultures, Others),By Disease Indication (CNS Infection ,Meningitis, Brain Abscess), Diarrheal Disease ( Shigellosis, Cholera, Enteric/Typhoid Fever),Respiratory Infections(Tuberculosis, Influenza, Bronchitis),Blood Infections(Malaria, Dengue, Infectious Mononucleosis, Others),STDs(Chlamydia, Aids, Syphills, Others)),By End User (Hospitals, Diagnostic Centers, Clinics, Government Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Mononucleosis, Others),STDs(Chlamydia, Aids, Syphills, Others)),By End User (Hospitals, Diagnostic Centers, Clinics, Government Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - ... Read More
-
Cancer Cachexia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4.5% during 2023-2028. Cancer cachexia refers to a multifactorial, host-phagocytic, wasting syndrome that is characterized by systematic inflammation, involuntary loss of lean body mass, negative ... Read More
-
Global Tuberculosis Treatment Market Growth (Status and Outlook) 2023-2029
... comprehensive analysis by region and market sector of projected Tuberculosis Treatment sales for 2023 through 2029. With Tuberculosis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in ... Read More
-
Antimicrobial Susceptibility Testing Market by Product (Manual, Automated), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion, Agar Diffusion, Genotyping), End User & Region - Global Forecasts to 2027
... is projected to reach USD 4.7 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 5.5% during the forecast period. The significant growth of the antimicrobial susceptibility testing market is largely ... Read More
-
Tuberculosis Treatment Drugs Market By Disease Type (Active Tuberculosis, Latent Tuberculosis), By Therapy Type (First Line Therapy, Second Line Therapy), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031
... and Industry Forecast, 2021-2031 The Tuberculosis Treatment Drugs Market valued for $1,929.96 million in 2021 and is estimated to reach $3,243.90 million by 2031, exhibiting a CAGR of 5.3% from 2022 to 2031. Tuberculosis (TB) ... Read More
-
Global Tuberculosis (TB) Treatment Market Growth (Status and Outlook) 2023-2029
... strain, will require several drugs at once. The most common medications used to treat tuberculosis include: Isoniazid Rifampin (Rifadin, Rimactane) Ethambutol (Myambutol) Pyrazinamide LPI (LP Information)' newest research report, the “Tuberculosis (TB) Treatment Industry Forecast” ... Read More
-
Global Mycobacterium Tuberculosis Testing Market Growth (Status and Outlook) 2023-2029
... Forecast” looks at past sales and reviews total world Mycobacterium Tuberculosis Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Mycobacterium Tuberculosis Testing sales for 2023 through 2029. With ... Read More
Research Assistance
